Brussels meeting: Advancing personalised treatment for childhood AML across Europe
In June, pediatric cancer experts from 16 countries gathered in Brussels for the annual meeting of the NOPHO-DB-SHIP consortium—an EU-wide collaboration working to improve outcomes for children with Acute Myeloid Leukemia (AML). In Sweden, the trial is coordinated by Lund University and Skåne University Hospital. At the center of this collaboration is the CHIP-AML22 trial—an international phase II
https://www.medicine.lu.se/article/brussels-meeting-advancing-personalised-treatment-childhood-aml-across-europe - 2025-10-03